Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Schellong

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Thrombosis Research|February 3, 2024
Incidence and risk factors of post-thrombotic syndrome in patients with isolated calf vein thrombosis. Findings from the GARFIELD-VTE registryPaolo Prandoni, Sylvia Haas, Meg Fluharty, et al.
Journal of Thrombosis and Thrombolysis|February 18, 2017
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER<sup>®</sup>, RE-COVER™ II, and RE-MEDY™Martin Feuring, Sam Schulman, Henry Eriksson, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|October 18, 2019
Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societiesRupert Bauersachs, Florian Langer, Christoph Kalka, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 25, 2003
Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosisHeike Kostka, Thomas Schwarz, Sebastian Schellong, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Highly Elevated Quantitative D-Dimer Assay Values Increase the Likelihood of Venous ThromboembolismSamuel Francis, Alexander Limkakeng, Hui Zheng, et al.
Circulation|June 20, 2007
Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) studyGiancarlo Agnelli, Alexander Gallus, Samuel Z Goldhaber, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 7, 2014
Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registryLauren P Cote, Steven Greenberg, Joseph A Caprini, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 7, 2015
Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study)Karl-Ludwig Schulte, Ernst Pilger, Sebastian Schellong, et al.
Journal of Thrombosis and Thrombolysis|August 28, 2021
Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE studySamuel Z Goldhaber, Walter Ageno, Ivan B Casella, et al.
Thrombosis and Haemostasis|July 28, 2020
Clinical Characteristics and Outcomes of Women Presenting with Venous Thromboembolism during Pregnancy and Postpartum Period: Findings from the RIETE RegistryIslam Y Elgendy, Annemarie Fogerty, Ángeles Blanco-Molina, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Thrombosis Research|February 3, 2024
Incidence and risk factors of post-thrombotic syndrome in patients with isolated calf vein thrombosis. Findings from the GARFIELD-VTE registryPaolo Prandoni, Sylvia Haas, Meg Fluharty, et al.
Journal of Thrombosis and Thrombolysis|February 18, 2017
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER<sup>®</sup>, RE-COVER™ II, and RE-MEDY™Martin Feuring, Sam Schulman, Henry Eriksson, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|October 18, 2019
Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societiesRupert Bauersachs, Florian Langer, Christoph Kalka, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 25, 2003
Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosisHeike Kostka, Thomas Schwarz, Sebastian Schellong, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Highly Elevated Quantitative D-Dimer Assay Values Increase the Likelihood of Venous ThromboembolismSamuel Francis, Alexander Limkakeng, Hui Zheng, et al.
Circulation|June 20, 2007
Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) studyGiancarlo Agnelli, Alexander Gallus, Samuel Z Goldhaber, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 7, 2014
Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registryLauren P Cote, Steven Greenberg, Joseph A Caprini, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 7, 2015
Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study)Karl-Ludwig Schulte, Ernst Pilger, Sebastian Schellong, et al.
Journal of Thrombosis and Thrombolysis|August 28, 2021
Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE studySamuel Z Goldhaber, Walter Ageno, Ivan B Casella, et al.
Thrombosis and Haemostasis|July 28, 2020
Clinical Characteristics and Outcomes of Women Presenting with Venous Thromboembolism during Pregnancy and Postpartum Period: Findings from the RIETE RegistryIslam Y Elgendy, Annemarie Fogerty, Ángeles Blanco-Molina, et al.
Pageof 12